These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36535544)

  • 1. The role of Cannabidiol and tetrahydrocannabivarin to overcome doxorubicin resistance in MDA-MB-231 xenografts in athymic nude mice.
    Kalvala AK; Nimma R; Bagde A; Surapaneni SK; Patel N; Arthur P; Sun L; Singh R; Kommineni N; Nathani A; Li Y; Singh M
    Biochimie; 2023 May; 208():19-30. PubMed ID: 36535544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer and chemosensitization effects of cannabidiol in 2D and 3D cultures of TNBC: involvement of GADD45α, integrin-α5, -β5, -β1, and autophagy.
    Surapaneni SK; Patel N; Sun L; Kommineni N; Kalvala AK; Gebeyehu A; Arthur P; Duke LC; Nimma R; G Meckes D; Singh M
    Drug Deliv Transl Res; 2022 Nov; 12(11):2762-2777. PubMed ID: 35217991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-induced neuropathic pain in rodents.
    Kumar Kalvala A; Bagde A; Arthur P; Kumar Surapaneni S; Ramesh N; Nathani A; Singh M
    Int Immunopharmacol; 2022 Jun; 107():108693. PubMed ID: 35303507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models.
    Patel N; Kommineni N; Surapaneni SK; Kalvala A; Yaun X; Gebeyehu A; Arthur P; Duke LC; York SB; Bagde A; Meckes DG; Singh M
    Int J Pharm; 2021 Sep; 607():120943. PubMed ID: 34324983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer.
    Fraguas-Sánchez AI; Fernández-Carballido A; Simancas-Herbada R; Martin-Sabroso C; Torres-Suárez AI
    Int J Pharm; 2020 Jan; 574():118916. PubMed ID: 31811927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Psychoactive Phytocannabinoids Inhibit Inflammation-Related Changes of Human Coronary Artery Smooth Muscle and Endothelial Cells.
    Teichmann E; Blessing E; Hinz B
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells.
    Yang F; Wang F; Liu Y; Wang S; Li X; Huang Y; Xia Y; Cao C
    Life Sci; 2018 Nov; 213():149-157. PubMed ID: 30352240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced oral bioavailability and in vitro evaluation of cannabidiol camel milk-derived exosome formulation in resistant MDA-MB-231 and MDA-MB-468 breast cancer cells.
    Aare M; Bagde A; Nathani A; Rishi AK; Singh M
    Int J Pharm; 2024 Sep; 663():124375. PubMed ID: 38914353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
    McPartland JM; Duncan M; Di Marzo V; Pertwee RG
    Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synergistic anticancer effect of CBD and DOX in osteosarcoma.
    Li J; Jiang W; Shan W; Luo A; Qu G; Zhang J; Luo X; Xia J
    Clin Transl Oncol; 2023 Aug; 25(8):2408-2418. PubMed ID: 36848028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparative Analysis on the Potential Anticancer Properties of Tetrahydrocannabinol, Cannabidiol, and Tetrahydrocannabivarin Compounds Through In Silico Approach.
    Gallardo AA; Gutierrez MR; Gomez LAJ; Delos Reyes PAO; Dones SAA; Dumbrique MMU; Lim HE; Liquido MIH; Macawile MML; Maglaqui EDAB; Manalo AMG; Devanadera MKP; Labrador AM
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):839-856. PubMed ID: 38546067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.
    Deiana S; Watanabe A; Yamasaki Y; Amada N; Arthur M; Fleming S; Woodcock H; Dorward P; Pigliacampo B; Close S; Platt B; Riedel G
    Psychopharmacology (Berl); 2012 Feb; 219(3):859-73. PubMed ID: 21796370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis.
    Silvestri C; Paris D; Martella A; Melck D; Guadagnino I; Cawthorne M; Motta A; Di Marzo V
    J Hepatol; 2015 Jun; 62(6):1382-90. PubMed ID: 25595882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
    Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P
    Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of transdermal permeation of cannabinoids and their pharmacodynamic evaluation in rats.
    Salau O; Bagde A; Kalvala A; Singh M
    Int J Pharm; 2022 Aug; 624():122016. PubMed ID: 35863593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with DHA Modifies the Response of MDA-MB-231 Breast Cancer Cells and Tumors from nu/nu Mice to Doxorubicin through Apoptosis and Cell Cycle Arrest.
    Newell M; Brun M; Field CJ
    J Nutr; 2019 Jan; 149(1):46-56. PubMed ID: 30601995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Second-Generation Proteasome Inhibitor and Doxorubicin Modulates IL-6, pSTAT-3 and NF-kB Activity in MDA-MB-231 Breast Cancer Cells.
    Vyas D; Lopez-Hisijos N; Shah P; Deshpande KS; Basson MD; Vyas A; Chaturvedi LS
    J Nanosci Nanotechnol; 2017 Jan; 17(1):175-85. PubMed ID: 29617099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.
    Jadoon KA; Ratcliffe SH; Barrett DA; Thomas EL; Stott C; Bell JD; O'Sullivan SE; Tan GD
    Diabetes Care; 2016 Oct; 39(10):1777-86. PubMed ID: 27573936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.